| abstract |
The disclosure provides methods of treating viral infection using trispecific binding proteins comprising four polypeptide chains that form three antigen binding sites that specifically bind a CD38 polypeptide (e.g, human and/or cynomolgus monkey CD38 polypeptides), a CD28 polypeptide, and a CD 3 polypeptide. |